ARYA Sciences Acquisition... (ARYE)
NASDAQ: ARYE
· Real-Time Price · USD
10.36
-0.02 (-0.19%)
At close: Jul 13, 2023, 9:52 PM
ARYA Sciences Acquisition Corp V Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 295.97K | 385.19K | 419.18K | 531.02K | 703.72K | 775.88K | 844.7K | 42.09K | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 153.29M | n/a | 150.38M | 149.72M | 149.48M | 149.53M | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 151.6M | n/a | n/a | n/a | n/a | 149.51M | 317.17K | 25K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 130K | n/a | 249.38K | 331.75K | 424.59K | 461K | 539.72K | n/a | n/a |
Total Current Assets | 425.97K | 542.19K | 668.55K | 862.77K | 1.13M | 1.24M | 1.38M | 42.09K | n/a |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 153.29M | 151.6M | 150.38M | 149.72M | 149.48M | 149.53M | 149.51M | 317.17K | 25K |
Total Assets | 153.72M | 152.14M | 151.05M | 150.58M | 150.61M | 150.77M | 150.9M | 359.26K | 25K |
Account Payables | 12.97K | 11.47K | 12.74K | 12.44K | 55.27K | 12.66K | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 150K | n/a |
Other Current Liabilities | 2.95M | 2.87M | 2.76M | 2.79M | 2.78M | 2.7M | 226.35K | 200.75K | 12.34K |
Total Current Liabilities | 2.96M | 2.88M | 2.78M | 2.81M | 2.84M | 2.72M | 226.35K | 350.75K | 12.34K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.62M | 2.62M | 2.62M | 5.23M | 5.23M | 5.23M | 5.23M | n/a | n/a |
Total Long-Term Liabilities | 2.62M | 2.62M | 2.62M | 5.23M | 5.23M | 5.23M | 5.23M | n/a | n/a |
Total Liabilities | 5.58M | 5.49M | 5.39M | 8.04M | 8.07M | 7.95M | 5.46M | 350.75K | 12.34K |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 150K | n/a |
Common Stock | 153.19M | 151.5M | 150.28M | 149.62M | 149.5M | n/a | n/a | 374.00 | 374.00 |
Retained Earnings | -5.05M | -4.85M | -4.62M | -7.08M | -6.96M | -6.68M | -4.06M | -16.49K | -12.34K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 148.14M | 146.65M | 145.66M | 142.54M | 142.54M | -6.68M | -4.06M | 8.51K | 12.66K |
Total Investments | 153.29M | n/a | 150.38M | 149.72M | 149.48M | 149.53M | n/a | n/a | n/a |